603168 莎普爱思
交易中 09-16 10:33:45
资讯
新帖
简况
莎普爱思：9月11日召开业绩说明会，投资者参与
证券之星 · 09-14 18:01
莎普爱思：9月11日召开业绩说明会，投资者参与
莎普爱思深陷业绩困局：主业疲软、并购踩雷，非经常性损益撑住账面盈利
新浪证券 · 09-11
莎普爱思深陷业绩困局：主业疲软、并购踩雷，非经常性损益撑住账面盈利
股市必读：莎普爱思新发布《莎普爱思关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-07
股市必读：莎普爱思新发布《莎普爱思关于召开2026年半年度业绩说明会的公告》
莎普爱思（603168）披露2026年半年度业绩说明会安排，9月3日股价下跌1.18%
证券之星 · 09-03
莎普爱思（603168）披露2026年半年度业绩说明会安排，9月3日股价下跌1.18%
莎普爱思（603168）2026年中报简析：净利润同比下降10.81%，三费占比上升明显
证券之星 · 09-01
莎普爱思（603168）2026年中报简析：净利润同比下降10.81%，三费占比上升明显
莎普爱思（603168）披露2026年半年度报告，8月31日股价下跌2.49%
证券之星 · 08-31
莎普爱思（603168）披露2026年半年度报告，8月31日股价下跌2.49%
莎普爱思2026年半年报：核心产品量价双降，主业扣非亏损
蓝鲸财经 · 08-31
莎普爱思2026年半年报：核心产品量价双降，主业扣非亏损
莎普爱思(603168)6月30日股东户数2.47万户，较上期减少6.94%
证券之星 · 08-30
莎普爱思(603168)6月30日股东户数2.47万户，较上期减少6.94%
莎普爱思(603168.SH)发布半年度业绩，归母净利润1950万元，同比下降10.81%
智通财经 · 08-30
莎普爱思(603168.SH)发布半年度业绩，归母净利润1950万元，同比下降10.81%
每周股票复盘：莎普爱思（603168）获维生素B12滴眼液注册证
证券之星 · 08-09
每周股票复盘：莎普爱思（603168）获维生素B12滴眼液注册证
莎普爱思最新公告：获得维生素B12滴眼液药品注册证书
证券之星 · 08-07
莎普爱思最新公告：获得维生素B12滴眼液药品注册证书
股市必读：莎普爱思（603168）今年截至6月2日累计跌幅已超20%
证券之星 · 06-03
股市必读：莎普爱思（603168）今年截至6月2日累计跌幅已超20%
莎普爱思（603168）披露实际控制人股份解质押公告，5月26日股价下跌2.63%
证券之星 · 05-26
莎普爱思（603168）披露实际控制人股份解质押公告，5月26日股价下跌2.63%
莎普爱思(603168.SH)：获得枸橼酸西地那非口崩片《药品注册证书》
智通财经 · 05-25
莎普爱思(603168.SH)：获得枸橼酸西地那非口崩片《药品注册证书》
股市必读：莎普爱思（603168）5月18日披露最新机构调研信息
证券之星 · 05-19
股市必读：莎普爱思（603168）5月18日披露最新机构调研信息
每周股票复盘：莎普爱思（603168）终止收购勤礼实业股权
证券之星 · 05-10
每周股票复盘：莎普爱思（603168）终止收购勤礼实业股权
时安生物与GSK就寡核苷酸新药达成超10亿美元授权合作；莎普爱思终止购买上海勤礼实业100%股权｜医药早参
每日经济新闻 · 05-07
时安生物与GSK就寡核苷酸新药达成超10亿美元授权合作；莎普爱思终止购买上海勤礼实业100%股权｜医药早参
莎普爱思(603168.SH)拟终止购买上海勤礼实业有限公司100%股权事项
智通财经 · 05-06
莎普爱思(603168.SH)拟终止购买上海勤礼实业有限公司100%股权事项
股市必读：莎普爱思(603168)股东户数2.66万户，较上期增加4.99%
证券之星 · 05-06
股市必读：莎普爱思(603168)股东户数2.66万户，较上期增加4.99%
每周股票复盘：莎普爱思（603168）Q1净利降394.89%
证券之星 · 05-02
每周股票复盘：莎普爱思（603168）Q1净利降394.89%
加载更多
公司概况
公司名称：
浙江莎普爱思药业股份有限公司
所属行业：
医药制造业
上市日期：
2014-07-02
主营业务：
浙江莎普爱思药业股份有限公司的主营业务是药品研发、生产、销售及医疗服务。公司的主要产品是苄达赖氨酸滴眼液、头孢克肟产品等。
发行价格：
21.85
{"stockData":{"symbol":"603168","market":"SH","secType":"STK","nameCN":"莎普爱思","latestPrice":5.57,"timestamp":1789526025000,"preClose":5.57,"halted":0,"volume":3136300,"delay":0,"changeRate":0,"floatShares":373000000,"shares":374000000,"eps":-0.6444,"marketStatus":"交易中","change":0,"latestTime":"09-16 10:33:45","open":5.55,"high":5.65,"low":5.44,"amount":17458200,"amplitude":0.0377,"askPrice":5.58,"askSize":70,"bidPrice":5.57,"bidSize":92,"shortable":0,"etf":0,"ttmEps":-0.6444,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1789529400000},"marketStatusCode":2,"adr":0,"adjPreClose":5.57,"symbolType":"stock","openAndCloseTimeList":[[1789522200000,1789529400000],[1789534800000,1789542000000]],"highLimit":6.13,"lowLimit":5.01,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":374126505,"isCdr":false,"pbRate":1.52,"roa":"--","roe":"1.43%","epsLYR":-0.64,"committee":0.64204,"marketValue":2084000000,"turnoverRate":0.0084,"status":2,"floatMarketCap":2075000000},"requestUrl":"/m/hq/s/603168","defaultTab":"news","newsList":[{"id":"2667657336","title":"莎普爱思：9月11日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657336","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667657336?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:01","pubTimestamp":1789380091,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月14日莎普爱思发布公告称公司于2026年9月11日召开业绩说明会。目前，公司儿童用药领域在研项目有硫酸阿托品滴眼液，用于控制儿童近视进展。莎普爱思主营业务：从事药品研发、生产、销售及医疗服务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400024483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666446065","title":"莎普爱思深陷业绩困局：主业疲软、并购踩雷，非经常性损益撑住账面盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2666446065","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666446065?lang=zh_cn&edition=full","pubTime":"2026-09-11 15:36","pubTimestamp":1789112160,"startTime":"0","endTime":"0","summary":"曾经凭借白内障滴眼液被大众熟知的莎普爱思，正持续面临经营层面的多重压力。02医疗服务并购接连失速，关联收购折戟暴露治理隐患医药制造、医疗服务是莎普爱思两大业务板块，而医疗服务板块已经连续多年成为业绩拖累项。整体来看，莎普爱思当下依靠投资收益等非经常性损益粉饰账面利润，主营业务已经陷入亏损。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5386170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603168","BK4588","CALF","XMMO","MYLD","KCE","BK0239","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665362799","title":"股市必读：莎普爱思新发布《莎普爱思关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665362799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665362799?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:18","pubTimestamp":1788715091,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，莎普爱思报收于5.86元，上涨0.0%，换手率1.58%，成交量5.88万手，成交额3463.27万元。当日关注点交易信息汇总：9月4日主力资金净流出275.3万元，占总成交额7.95%； 公司公告汇总：莎普爱思将于9月11日15:30-16:30通过价值在线召开2026年半年度业绩说明会，董事长兼总经理林弘立等高管将出席。出席人员包括董事长兼总经理林弘立、独立董事陈胜群、财务总监林秀松和董事会秘书黄明雄。说明会结束后，可登录相关平台查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664187075","title":"莎普爱思（603168）披露2026年半年度业绩说明会安排，9月3日股价下跌1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664187075","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664187075?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:20","pubTimestamp":1788445229,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，莎普爱思报收于5.86元，较前一交易日下跌1.18%，最新总市值为21.92亿元。该股当日开盘6.01元，最高6.04元，最低5.84元，成交额达4535.68万元，换手率为2.06%。近日，莎普爱思发布《关于召开2026年半年度业绩说明会的公告》。公告显示，公司将于2026年9月11日15:30-16:30通过网络互动方式在价值在线召开2026年半年度业绩说明会，介绍公司经营业绩、发展战略等情况。说明会结束后，可登录相关平台查看会议内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300042416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854358","title":"莎普爱思（603168）2026年中报简析：净利润同比下降10.81%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854358","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664854358?lang=zh_cn&edition=full","pubTime":"2026-09-01 06:06","pubTimestamp":1788214014,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期莎普爱思发布2026年中报。截至本报告期末，公司营业总收入1.97亿元，同比下降16.77%，归母净利润1950.03万元，同比下降10.81%。按单季度数据看，第二季度营业总收入9798.38万元，同比下降27.07%，第二季度归母净利润4560.44万元，同比上升250.51%。本报告期莎普爱思三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达33.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100004704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077343","title":"莎普爱思（603168）披露2026年半年度报告，8月31日股价下跌2.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077343","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663077343?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:02","pubTimestamp":1788174155,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，莎普爱思报收于5.88元，较前一交易日下跌2.49%，最新总市值为22亿元。该股当日开盘6.03元，最高6.09元，最低5.74元，成交额达7703.85万元，换手率为3.52%。公司于近日披露《2026年半年度报告》。公告显示，截至2026年6月30日，公司总资产为1,809,251,267.64元，较上年度末减少3.36%；归属于上市公司股东的净资产为1,370,712,802.64元，同比增长1.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100029978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663716260","title":"莎普爱思2026年半年报：核心产品量价双降，主业扣非亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2663716260","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663716260?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:50","pubTimestamp":1788169807,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月31日讯，8月30日，莎普爱思 公布2026年中报，公司依托“药+医”双轮驱动战略，受制于核心产品销售价格及销量下滑，报告期业绩呈现营收与利润双降态势；同时，非经常性损益对净利润形成显著支撑，主业盈利能力承压。报告期内，商品销售收入1.22亿元，诊疗服务收入0.59亿元。业绩下滑主要源于医药制造板块核心产品售价及销量双重承压，导致营业收入同比减少近4,000万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788148365778861869","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663049486","title":"莎普爱思(603168)6月30日股东户数2.47万户，较上期减少6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663049486","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663049486?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:06","pubTimestamp":1788080800,"startTime":"0","endTime":"0","summary":"证券之星消息，近日莎普爱思披露，截至2026年6月30日公司股东户数为2.47万户，较3月31日减少1846.0户，减幅为6.94%。在化学制药行业个股中，莎普爱思股东户数低于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年3月31日至2026年6月30日，莎普爱思区间跌幅为33.05%，在此期间股东户数减少1846.0户，减幅为6.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000010978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663691049","title":"莎普爱思(603168.SH)发布半年度业绩，归母净利润1950万元，同比下降10.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663691049","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663691049?lang=zh_cn&edition=full","pubTime":"2026-08-30 16:41","pubTimestamp":1788079314,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)披露2026年半年度报告，报告期公司实现营业收入1.97亿元，同比下降16.77%;归母净利润1950万元，同比下降10.81%;扣非净利润亏损3136万元，同比由盈转亏;基本每股收益0.05元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488991.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"莎普爱思(603168.SH)发布半年度业绩，归母净利润1950万元，同比下降10.81%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658675149","title":"每周股票复盘：莎普爱思（603168）获维生素B12滴眼液注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2658675149","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658675149?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:59","pubTimestamp":1786215548,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，莎普爱思报收于5.38元，较上周的5.2元上涨3.46%。本周，莎普爱思8月4日盘中最高价报5.51元。本周关注点公司公告汇总：莎普爱思获维生素B12滴眼液《药品注册证书》，适用于缓解调节性眼疲劳症状。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657119846","title":"莎普爱思最新公告：获得维生素B12滴眼液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2657119846","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657119846?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:37","pubTimestamp":1786095457,"startTime":"0","endTime":"0","summary":"莎普爱思(603168.SH)公告称，公司近日收到国家药品监督管理局核发的维生素B12滴眼液《药品注册证书》，该药品适用于缓解调节性眼疲劳症状。本次获批将进一步丰富公司产品品类，优化产品布局，但药品未来生产和销售受多重因素影响，对公司业绩的影响存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700030048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640292371","title":"股市必读：莎普爱思（603168）今年截至6月2日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640292371","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640292371?lang=zh_cn&edition=full","pubTime":"2026-06-03 04:05","pubTimestamp":1780430721,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，莎普爱思报收于5.73元，下跌3.54%，换手率1.61%，成交量5.99万手，成交额3456.63万元。交易信息汇总股价提醒6月2日莎普爱思收盘报5.73元，跌3.54%，当日成交3456.63万元。根据收盘数据统计，该股已连续2日下跌，当年累计跌幅21.24%。前10个交易日资金流向情况：主力资金累计净流出592.05万元，股价累计下跌14.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300006284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638543258","title":"莎普爱思（603168）披露实际控制人股份解质押公告，5月26日股价下跌2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638543258","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638543258?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:48","pubTimestamp":1779806900,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，莎普爱思报收于5.92元，较前一交易日下跌2.63%，最新总市值为22.15亿元。近日，莎普爱思发布《关于实际控制人股份解质押的公告》。公告显示，公司实际控制人林弘远及其一致行动人合计持有公司股份121,965,305股，占公司总股本的32.60%。林弘远于2026年5月22日解除质押11,013,700股，占其持股的38.04%，占公司总股本的2.94%。本次解押后，林弘远及其一致行动人累计质押股份42,612,083股，占其持股总数的34.94%，占公司总股本的11.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638536462","title":"莎普爱思(603168.SH)：获得枸橼酸西地那非口崩片《药品注册证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2638536462","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638536462?lang=zh_cn&edition=full","pubTime":"2026-05-25 16:40","pubTimestamp":1779698405,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司收到国家药品监督管理局核发的枸橼酸西地那非口崩片的《药品注册证书》。据悉，本次获批的枸橼酸西地那非口崩片适用于治疗勃起功能障碍。截至本公告披露日，公司针对该药品的累计研发投入约为991.5万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"莎普爱思(603168.SH)：获得枸橼酸西地那非口崩片《药品注册证书》","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636100399","title":"股市必读：莎普爱思（603168）5月18日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2636100399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636100399?lang=zh_cn&edition=full","pubTime":"2026-05-19 01:59","pubTimestamp":1779127149,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，莎普爱思报收于6.38元，下跌0.31%，换手率2.03%，成交量7.57万手，成交额4783.43万元。机构调研要点苄达赖氨酸滴眼液一致性评价方面，2026年度公司持续推进相关工作，已完成上市后临床研究并上报国家药监局，后续进展将依规履行信息披露义务。公司目前暂无购股份计划，如有将严格按照监管要求履行信息披露义务。后续分红恢复条件详见公司2026年4月15日披露的《莎普爱思未来三年股东分红回报规划》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900002211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634412183","title":"每周股票复盘：莎普爱思（603168）终止收购勤礼实业股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2634412183","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634412183?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:29","pubTimestamp":1778354949,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，莎普爱思报收于6.71元，较上周的6.74元下跌0.45%。本周，莎普爱思5月6日盘中最高价报6.8元。本周关注点公司公告汇总：莎普爱思决定终止拟购买上海勤礼实业有限公司100%股权暨关联交易事项。公司公告汇总莎普爱思第六届董事会第十五次会议于2026年5月6日以通讯方式召开，应出席董事9人，实际出席9人，会议决议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633512166","title":"时安生物与GSK就寡核苷酸新药达成超10亿美元授权合作；莎普爱思终止购买上海勤礼实业100%股权｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2633512166","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633512166?lang=zh_cn&edition=full","pubTime":"2026-05-07 07:00","pubTimestamp":1778108408,"startTime":"0","endTime":"0","summary":"丨2026年5月7日星期四丨NO.1时安生物与GSK就寡核苷酸新药达成超10亿美元授权合作时安生物宣布，与葛兰素史克（GSK）就SA030达成一项中国市场以外的全球独家许可协议。葛兰素史克将支付首付款，以及未来基于成功达成的开发、注册与商业化里程碑付款，总额最高达10.05亿美元；同时将按中国以外的全球产品净销售额支付分级特许权使用费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605073729101163.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605073729101163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK1574","603168","BK4532","BK4585","BK1161","09939","BK1515","GSKH","LU1829250122.USD","BK4588","159938","GSK","GSK.UK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633108188","title":"莎普爱思(603168.SH)拟终止购买上海勤礼实业有限公司100%股权事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2633108188","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633108188?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:17","pubTimestamp":1778059032,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，公司决定终止购买上海勤礼实业有限公司100%股权暨关联交易的事项。本次终止购买股权暨关联交易事项不会影响公司的正常经营，不会对公司的经营发展和财务状况产生不良影响，不会损害公司及全体股东的利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633692798","title":"股市必读：莎普爱思(603168)股东户数2.66万户，较上期增加4.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633692798","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633692798?lang=zh_cn&edition=full","pubTime":"2026-05-06 05:20","pubTimestamp":1778016023,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，莎普爱思报收于6.74元，上涨0.0%，换手率2.27%，成交量8.46万手，成交额5673.7万元。来自公司公告汇总：莎普爱思第六届董事会第十四次会议审议通过《关于2026年第一季度报告的议案》，决议合法有效。股本股东变化股东户数变动截至2026年3月31日公司股东户数为2.66万户，较12月31日增加1263.0户，增幅为4.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632013628","title":"每周股票复盘：莎普爱思（603168）Q1净利降394.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632013628","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632013628?lang=zh_cn&edition=full","pubTime":"2026-05-02 05:47","pubTimestamp":1777672031,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，莎普爱思报收于6.74元，较上周的6.5元上涨3.69%。本周，莎普爱思4月29日盘中最高价报6.8元。股本股东变化截至2026年3月31日，莎普爱思股东户数为2.66万户，较2025年12月31日增加1263.0户，增幅4.99%。公司公告汇总浙江莎普爱思药业股份有限公司2026年第一季度报告显示，报告期内营业收入为98,522,734.42元，同比下降3.15%；利润总额为-25,814,816.70元，上年同期为9,047,476.95元；归属于上市公司股东的净利润为-26,104,017.00元，同比下降394.89%；基本每股收益为-0.07元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789526036127,"stockEarnings":[{"period":"1week","weight":-0.0824},{"period":"1month","weight":0.0018},{"period":"3month","weight":0.0965},{"period":"6month","weight":-0.2544},{"period":"1year","weight":-0.314},{"period":"ytd","weight":-0.2432}],"compareEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0593},{"period":"6month","weight":-0.0355},{"period":"1year","weight":0.001},{"period":"ytd","weight":-0.0263}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江莎普爱思药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24741人(较上一季度减少6.94%)","perCapita":"15056股","listingDate":"2014-07-02","address":"浙江省嘉兴市平湖市经济开发区新明路1588号","registeredCapital":"37412万元","survey":" 浙江莎普爱思药业股份有限公司的主营业务是药品研发、生产、销售及医疗服务。公司的主要产品是苄达赖氨酸滴眼液、头孢克肟产品等。","listedPrice":21.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莎普爱思,603168,莎普爱思股票,莎普爱思股票老虎,莎普爱思股票老虎国际,莎普爱思行情,莎普爱思股票行情,莎普爱思股价,莎普爱思股市,莎普爱思股票价格,莎普爱思股票交易,莎普爱思股票购买,莎普爱思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}